enVVeno Medical NVNO Income Statement (2017-2026)

NASDAQ NVNO
$10.53 +0.05 (+0.48%)
At close: Aug 20, 2026 · 10:11 AM UTC
Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.27M0.27M0.27M321.000.27M0.27M0.27M0.27M0.27M0.38M0.38M0.38M0.50M0.50M0.50M0.55M0.58M0.66M0.66M0.67M
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)
1.23M1.78M1.55M3.07M2.49M2.80M3.60M4.21M2.80M2.98M3.05M2.83M2.86M3.51M2.56M2.89M2.58M1.95M2.11M2.08M
Selling, General & Administrative (Quarter)
1.48M7.21M3.78M3.91M3.66M3.66M3.20M2.60M2.55M3.30M2.45M2.63M3.31M3.19M2.40M4.16M2.30M2.06M1.95M1.72M
Other Operating Expenses (Quarter)
-0.00M
Operating Expenses (Quarter)
2.71M8.99M5.33M6.99M6.15M6.46M6.80M6.81M5.35M6.28M5.50M5.45M6.17M6.70M4.95M7.05M4.88M4.01M4.06M3.80M
Operating Income (Quarter)
-2.71M-8.99M-5.33M-6.99M-6.15M-6.46M-6.80M-6.81M-5.35M-6.28M-5.50M-5.45M-6.17M-6.70M-4.95M-7.05M-4.88M-4.01M-4.06M-3.80M
EBIT (Quarter)
-2.71M-8.99M-5.33M-6.99M-6.15M-6.46M-6.80M-6.81M-5.35M-6.28M-5.50M-5.45M-6.17M-6.70M-4.95M-7.05M-4.88M-4.01M-4.06M-3.80M
Non-operating items
Non Operating Investment Income (Quarter)
-0.11M-0.02M0.18M0.08M0.17M0.15M0.68M0.41M0.38M0.01M0.42M-0.19M-0.08M-0.04M-1.26M0.24M0.21M
Interest & Investment Income (Quarter)
0.01M0.01M0.04M0.07M0.04M0.04M0.04M0.04M0.05M0.06M0.07M0.09M0.16M0.22M0.20M0.17M0.10M0.02M0.01M
Other Non Operating Income (Quarter)
0.31M-0.02M
Non Operating Income (Quarter)
0.32M0.01M0.01M-0.08M0.05M0.28M0.41M0.34M0.35M0.63M0.51M0.50M0.53M0.47M0.45M0.35M0.34M0.28M0.21M0.20M
Net income details
EBT (Quarter)
-3.06M-9.33M-5.33M-6.99M-6.10M-6.71M-6.80M-6.81M-5.30M-7.67M-5.44M-5.38M-6.08M-6.84M-4.74M-6.85M-4.71M-3.94M-4.04M-3.79M
Profit After Tax (Quarter)
-2.39M-8.99M-5.33M-7.06M-6.10M-6.18M-6.39M-6.47M-5.00M-5.65M-4.99M-4.96M-5.64M-6.23M-4.50M-6.69M-4.54M-3.74M-3.85M-3.60M
Income from Continuing Operations (Quarter)
-3.06M-9.33M-5.33M-6.99M-6.10M-6.71M-6.80M-6.81M-5.30M-7.67M-5.44M-5.38M-6.08M-6.84M-4.74M-6.85M-4.71M-3.94M-4.04M-3.79M
Consolidated Net Income (Quarter)
-3.06M-9.33M-5.33M-6.99M-6.10M-6.71M-6.80M-6.81M-5.30M-7.67M-5.44M-5.38M-6.08M-6.84M-4.74M-6.85M-4.71M-3.94M-4.04M-3.79M
Income towards Parent Company (Quarter)
-3.06M-9.33M-5.33M-6.99M-6.10M-6.71M-6.80M-6.81M-5.30M-7.67M-5.44M-5.38M-6.08M-6.84M-4.74M-6.85M-4.71M-3.94M-4.04M-3.79M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-2.39M-8.99M-5.33M-6.99M-6.10M-6.71M-6.80M-6.81M-5.30M-7.67M-5.44M-5.38M-6.08M-6.84M-4.74M-6.85M-4.71M-3.94M-4.04M-3.79M
Additional items
EPS (Basic) (Quarter)
-9.11-36.24-16.63-0.02M-19.02-20.93-21.18-21.24-16.53-21.82-11.87-11.72-13.24-13.97-8.14-11.79-8.18-6.68-6.18-5.64
EPS (Diluted) (Quarter)
-21.78-19.02-20.93-21.18-21.24-16.53-21.82-11.87-11.72-13.24-13.97-8.14-11.79-8.18-6.68-6.18-5.64
Shares Outstanding (Quarter)
0.26M0.25M0.32M321.000.32M0.32M0.32M0.32M0.32M0.35M0.46M0.46M0.46M0.49M0.58M0.58M0.58M0.59M0.65M0.67M
Shares Outstanding (Diluted) (Quarter)
0.32M0.32M0.32M0.32M0.32M0.32M0.35M0.46M0.46M0.46M0.49M0.58M0.58M0.58M0.59M0.65M0.67M
EBITDA (Quarter)
-2.71M-8.99M-5.33M-6.99M-6.15M-6.46M-6.80M-6.81M-5.35M-6.28M-5.50M-5.45M-6.17M-6.70M-4.95M-7.05M-4.88M-4.01M-4.06M-3.80M
Interest Expenses (Quarter)
0.36M0.34M0.01M0.04M0.03M0.30M0.04M0.04M1.44M0.31M0.03M